Confo Therapeutics

Technologiepark 30
9052 Gent Zwijnaarde
BE
Confo Therapeutics
Foundation date
11/06/2015
Sector
#Biotechnology - TherapeuticsSubsector
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets.
This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments.
Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals and scientists from successful biopharmaceutical companies, Confo Therapeutics benefits from the rich scientific and innovative ecosystem in Belgium.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture
8 hours ago
Read more
-
Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology
1 day ago
Read more
-
Fat creates an ideal environment for metastatic breast tumors
1 day ago
Read more
Jobs
More jobs-
07/02/23
Brussels
Postdoctoral position in cancer immunology and the tumor immune microenvironment
Permanent
VIB -
-